0001214659-19-000455.txt : 20190122
0001214659-19-000455.hdr.sgml : 20190122
20190122190029
ACCESSION NUMBER: 0001214659-19-000455
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190117
FILED AS OF DATE: 20190122
DATE AS OF CHANGE: 20190122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnson Craig A
CENTRAL INDEX KEY: 0001370348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 19536299
MAIL ADDRESS:
STREET 1: C/O PURE BIOSCIENCE
STREET 2: 1725 GILLESPIE WAY
CITY: EL CAJON
STATE: CA
ZIP: 92020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
marketforms-43762.xml
PRIMARY DOCUMENT
X0306
4
2019-01-17
0001576263
Mirati Therapeutics, Inc.
MRTX
0001370348
Johnson Craig A
C/O MIRATI THERAPEUTICS INC.
9393 TOWN CENTRE DRIVE, STE 200
SAN DIEGO
CA
92121
true
false
false
false
Non-Qualified Stock Option (right to buy)
64.14
2019-01-17
4
A
false
11000
0
A
2029-01-16
Common Stock
11000
11000
D
The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant.
/s/ Vickie Reed, Attorney-in-Fact
2019-01-22